NANOSTRUCTURED LIPID CARRIERS FOR TRANSDERMAL DRUG DELIVERY

Authors

  • DOAA H. HASSAN Department of Pharmaceutics, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), 6th of October, Giza, (12566) Egypt
  • JOSEPH N. SHOHDY Department of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), 6th of October, Giza, (12566) Egypt
  • MOHAM EL-NABARAWI Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Giza, Egypt
  • DOAA AHMED EL-SETOUHY Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Giza, Egypt
  • MENNA M. ABDELLATIF Department of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), 6th of October, Giza, (12566) Egypt

DOI:

https://doi.org/10.22159/ijap.2022v14i4.44564

Keywords:

Nanostructured lipid carriers, Transdermal drug delivery, Controlled release

Abstract

Transdermal drug delivery offers many advantages over oral delivery, such as avoiding first-pass metabolism, enhancing the bioavailability of poorly soluble drugs, and providing better patient compliance. However, only small lipophilic molecules can be delivered across the stratum corneum, the outermost layer of the skin. Unfortunately, the delivery of larger molecules remains a challenge. Nanostructured lipid carriers (NLCs) are second-generation lipid nanocarriers composed of biocompatible solid lipids, liquid lipids, surfactants, and co-surfactants. NLCs can be loaded with various classes of drugs, provide a controlled drug release profile, enhance drug stability, and be scaled up without needing organic solvents. This review article discusses the features, composition, formulation processes, and characterization of NLCs and their potential use in transdermal drug delivery.

Downloads

Download data is not yet available.

References

Sharma G, Thakur K, Raza K, Singh B, Katare OP. Nanostructured lipid carriers: a new paradigm in topical delivery for dermal and transdermal applications. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2017;34(4):355-86. doi: 10.1615/CritRevTherDrugCarrierSyst.2017019047.

Wang C, Jiang X, Zeng Y, Terry RN, Li W. Rapidly separable microneedle patches for controlled release of therapeutics for long-acting therapies. Medicine in Drug Discovery. 2022;13:100118. doi: https://doi.org/10.1016/j.medidd.2021.100118.

Souto EB, Fangueiro JF, Fernandes AR, Cano A, Sanchez-Lopez E, Garcia ML, et al. Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery. Heliyon. 2022;8(2):e08938. doi: https://doi.org/10.1016/j.heliyon.2022.e08938.

Priyanka P, Sri Rekha M, Devi AS. Review on formulation and evaluation of solid lipid nanoparticles for vaginal application. International Journal of Pharmacy and Pharmaceutical Sciences. 2022;14:1–8.

Haider M, Abdin SM, Kamal L, Orive G. Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review. Pharmaceutics. 2020;12(3):288 doi: 10.3390/pharmaceutics12030288.

Chauhan I, Yasir M, Verma M, Singh AP. Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery. Advanced pharmaceutical bulletin. 2020;10(2):150-65. doi: 10.34172/apb.2020.021

Czajkowska-Kośnik A, Szekalska M, Winnicka K. Nanostructured lipid carriers: A potential use for skin drug delivery systems. Pharmacological Reports. 2019;71(1):156-66. doi: https://doi.org/10.1016/j.pharep.2018.10.008.

Ghasemiyeh P, Mohammadi-Samani S. Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages. Drug design, development and therapy. 2020;14:3271-89. doi: 10.2147/DDDT.S264648. PubMed PMID: 32848366.

Shahzadi I, Fürst A, Knoll P, Bernkop-Schnürch A. Nanostructured Lipid Carriers (NLCs) for Oral Peptide Drug Delivery: About the Impact of Surface Decoration. Pharmaceutics. 2021;13(8):1312. doi: 10.3390/pharmaceutics13081312.

Souto EB, Baldim I, Oliveira WP, Rao R, Yadav N, Gama FM, et al. SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opinion on Drug Delivery. 2020;17(3):357-77. doi: 10.1080/17425247.2020.1727883.

Doktorovova S, Shegokar R, Souto EB. Chapter 30 - Role of Excipients in formulation development and biocompatibility of lipid nanoparticles (SLNs/NLCs). In: Ficai D, Grumezescu AM, editors. Nanostructures for Novel Therapy: Elsevier; 2017. p. 811-43.

Fatima N, Rehman S, Nabi B, Baboota S, Ali J. Harnessing nanotechnology for enhanced topical delivery of clindamycin phosphate. Journal of Drug Delivery Science and Technology. 2019;54:101253. doi: https://doi.org/10.1016/j.jddst.2019.101253.

Zielińska A, Ferreira NR, Durazzo A, Lucarini M, Cicero N, Mamouni SE, et al. Development and Optimization of Alpha-Pinene-Loaded Solid Lipid Nanoparticles (SLN) Using Experimental Factorial Design and Dispersion Analysis. Molecules. 2019;24(15):2683. PubMed PMID: doi:10.3390/molecules24152683.

Pereira I, Zielińska A, Ferreira NR, Silva AM, Souto EB. Optimization of linalool-loaded solid lipid nanoparticles using experimental factorial design and long-term stability studies with a new centrifugal sedimentation method. International Journal of Pharmaceutics. 2018;549(1):261-70. doi: https://doi.org/10.1016/j.ijpharm.2018.07.068.

Souto EB, Zielinska A, Souto SB, Durazzo A, Lucarini M, Santini A, et al. (+)-Limonene 1,2-Epoxide-Loaded SLNs: Evaluation of Drug Release, Antioxidant Activity, and Cytotoxicity in an HaCaT Cell Line. International Journal of Molecular Sciences. 2020;21(4):1449. doi: 10.3390/ijms21041449.

Baghel S, Nair VS, Pirani A, Sravani AB, Bhemisetty B, Ananthamurthy K, et al.. Luliconazole‐loaded nanostructured lipid carriers for topical treatment of superficial Tinea infections. Dermatologic Therapy. Dermatologic Therapy; 2020;33(6):1-12. https://doi.org/10.1111/dth.13959

De Souza IDL, Saez V, De Campos VEB, Mansur CRE. Size and Vitamin E Release of Nanostructured Lipid Carriers with Different Liquid Lipids, Surfactants and Preparation Methods. Macromolecular Symposia; 2019;383(1):1800011.

Nitthikan N, Leelapornpisid P, Natakankitkul S, Chaiyana W, Mueller M, Viernstein H, et al. Improvement of Stability and Transdermal Delivery of Bioactive Compounds in Green Robusta Coffee Beans Extract Loaded Nanostructured Lipid Carriers. Journal of Nanotechnology. 2018;2018:7865024. doi: 10.1155/2018/7865024.

Gao S, Tian B, Han J, Zhang J, Shi Y, Lv Q, et al. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema. International Journal of nanomedicine. 2019;14:6135-50. doi: 10.2147/IJN.S205295.

Salvi VR, Pawar P. Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier. Journal of Drug Delivery Science and Technology. 2019;51:255-67. doi: https://doi.org/10.1016/j.jddst.2019.02.017.

Samimi S, Maghsoudnia N, Eftekhari RB, Dorkoosh F. Chapter 3 - Lipid-Based Nanoparticles for Drug Delivery Systems. In: Mohapatra SS, Ranjan S, Dasgupta N, Mishra RK, Thomas S, editors. Characterization and Biology of Nanomaterials for Drug Delivery: Elsevier; 2019. p. 47-76.

Bhatt P, Kelly S, Sutariya V. Nanoscale delivery systems in treatment of posterior ocular neovascularization: strategies and potential applications. Therapeutic delivery. 2019;10(11):737-47.

Ahmad J, Rizwanullah M, Amin S, Warsi MH, Ahmad MZ, Barkat M. Nanostructured lipid carriers (NLCs): Nose-to-brain delivery and theranostic application. Current Drug Metabolism. 2020;21(14):1136-43.

Battaglia L, Ugazio E. Lipid Nano- and Microparticles: An Overview of Patent-Related Research. Journal of Nanomaterials. 2019;2019:2834941. doi: 10.1155/2019/2834941.

Srichaivatana K, Ounaroon A, Tiyaboonchai W. Development and characterization of piper retrofractum extract loaded mucoadhesive nanostructured lipid carriers for topical oral drug delivery. Int J Pharm Pharm Sci. 2017;9:79-86.

Duong V-A, Nguyen T-T-L, Maeng H-J, Chi S-C. Nanostructured lipid carriers containing ondansetron hydrochloride by cold high-pressure homogenization method: Preparation, characterization, and pharmacokinetic evaluation. Journal of Drug Delivery Science and Technology. 2019;53:101185. doi: https://doi.org/10.1016/j.jddst.2019.101185.

Makoni PA, Wa Kasongo K, Walker RB. Short Term Stability Testing of Efavirenz-Loaded Solid Lipid Nanoparticle (SLN) and Nanostructured Lipid Carrier (NLC) Dispersions. Pharmaceutics. 2019;11(8): 397. doi: 10.3390/pharmaceutics11080397.

Upreti T, Senthil V. Nanostructured lipid carrier system for the treatment for skin disease-a review. JSM Nanotechnol Nanomed. 2017;5(3):1059-64.

Souto EB, Baldim I, Oliveira WP, Rao R, Yadav N, Gama FM, et al. SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opinion on Drug Delivery. 2020;17(3):357-77. doi: 10.1080/17425247.2020.1727883.

Salvi VR, Pawar P. Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier. Journal of Drug Delivery Science and Technology. 2019;51:255-67. doi: https://doi.org/10.1016/j.jddst.2019.02.017.

Gordillo-Galeano A, Mora-Huertas CE. Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release. European Journal of Pharmaceutics and Biopharmaceutics. 2018;133:285-308. doi: https://doi.org/10.1016/j.ejpb.2018.10.017.

Salvioni L, Morelli L, Ochoa E, Labra M, Fiandra L, Palugan L, et al. The emerging role of nanotechnology in skincare. Advances in Colloid and Interface Science. 2021;293:102437. doi: https://doi.org/10.1016/j.cis.2021.102437.

Abdellatif MM, Elakkad YE, Elwakeel AA, Allam RM, Mousa MR. Formulation and characterization of propolis and tea tree oil nanoemulsion loaded with clindamycin hydrochloride for wound healing: In-vitro and in-vivo wound healing assessment. Saudi Pharmaceutical Journal. 2021;29(11):1238-49. doi: https://doi.org/10.1016/j.jsps.2021.10.004.

Jazuli I, Annu, Nabi B, moolakkadath T, Alam T, Baboota S, et al. Optimization of Nanostructured Lipid Carriers of Lurasidone Hydrochloride Using Box-Behnken Design for Brain Targeting: In Vitro and In Vivo Studies. Journal of Pharmaceutical Sciences. 2019;108(9):3082-90. doi: https://doi.org/10.1016/j.xphs.2019.05.001.

Kapoor H, Aqil M, Imam SS, Sultana Y, Ali A. Formulation of amlodipine nano lipid carrier: Formulation design, physicochemical and transdermal absorption investigation. Journal of Drug Delivery Science and Technology. 2019;49:209-18. doi: https://doi.org/10.1016/j.jddst.2018.11.004.

Pandey SS, Patel MA, Desai DT, Patel HP, Gupta AR, Joshi SV, et al. Bioavailability enhancement of repaglinide from transdermally applied nanostructured lipid carrier gel: Optimization, in vitro and in vivo studies. Journal of Drug Delivery Science and Technology. 2020;57:101731. doi: https://doi.org/10.1016/j.jddst.2020.101731.

Nguyen CN, Nguyen TTT, Nguyen HT, Tran TH. Nanostructured lipid carriers to enhance transdermal delivery and efficacy of diclofenac. Drug Delivery and Translational Research. 2017;7(5):664-73. doi: 10.1007/s13346-017-0415-2.

Garg NK, Tandel N, Bhadada SK, Tyagi RK. Nanostructured Lipid Carrier-Mediated Transdermal Delivery of Aceclofenac Hydrogel Present an Effective Therapeutic Approach for Inflammatory Diseases. Frontiers in pharmacology. 2021;12:713616. doi: 10.3389/fphar.2021.713616. PubMed PMID: 34616297.

Ahmed S, Mahmood S, Danish Ansari M, Gull A, Sharma N, Sultana Y. Nanostructured lipid carrier to overcome stratum corneum barrier for the delivery of agomelatine in rat brain; formula optimization, characterization and brain distribution study. International Journal of Pharmaceutics. 2021;607:121006. doi: https://doi.org/10.1016/j.ijpharm.2021.121006.

Bashiri S, Ghanbarzadeh B, Ayaseh A, Dehghannya J, Ehsani A, Ozyurt H. Essential oil-loaded nanostructured lipid carriers: The effects of liquid lipid type on the physicochemical properties in beverage models. Food Bioscience. 2020;35:100526. doi: https://doi.org/10.1016/j.fbio.2020.100526.

Sainaga Jyothi VGS, Ghouse SM, Khatri DK, Nanduri S, Singh SB, Madan J. Lipid nanoparticles in topical dermal drug delivery: Does chemistry of lipid persuade skin penetration? Journal of Drug Delivery Science and Technology. 2022;69:103176. doi: https://doi.org/10.1016/j.jddst.2022.103176.

Mohamed M, Makky A, Abdellatif M. Liposomal gels as carriers for safer topical delivery of tazarotene. Journal of Pharmaceutical Research and Opinion.2013;3(11): 82-90.

Pivetta TP, Silva LB, Kawakami CM, Araújo MM, Del Lama MPFM, Naal RMZG, et al. Topical formulation of quercetin encapsulated in natural lipid nanocarriers: Evaluation of biological properties and phototoxic effect. Journal of Drug Delivery Science and Technology. 2019;53:101148. doi: https://doi.org/10.1016/j.jddst.2019.101148.

Khurana S, Jain NK, Bedi PMS. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam. Life Sciences. 2013;93(21):763-72. doi: https://doi.org/10.1016/j.lfs.2013.09.027.

Saedi A, Rostamizadeh K, Parsa M, Dalali N, Ahmadi N. Preparation and characterization of nanostructured lipid carriers as drug delivery system: Influence of liquid lipid types on loading and cytotoxicity. Chemistry and Physics of Lipids. 2018;216:65-72. doi: https://doi.org/10.1016/j.chemphyslip.2018.09.007.

Falsafi SR, Rostamabadi H, Assadpour E, Jafari SM. Morphology and microstructural analysis of bioactive-loaded micro/nanocarriers via microscopy techniques; CLSM/SEM/TEM/AFM. Advances in Colloid and Interface Science. 2020;280:102166. doi: https://doi.org/10.1016/j.cis.2020.102166.

Shah J, Patel S, Bhairy S, Hirlekar R. Formulation optimization, characterization and in vitro anticancer activity of curcumin loaded nanostructured lipid carriers. International Journal of Current Pharmaceutical Research. 2022;14: 31–43.

Nnamani PO, Hansen S, Windbergs M, Lehr C-M. Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application. International Journal of Pharmaceutics. 2014;477(1):208-17. doi: https://doi.org/10.1016/j.ijpharm.2014.10.004.

Solís AC, Bento D, Nunes S, Valente A, Pais A, Vitorino C. Rethinking transdermal drug delivery using PVA-NLC based films. Polymer. 2021;230:124032. doi: https://doi.org/10.1016/j.polymer.2021.124032.

Brito Raj S, Chandrasekhar KB, Reddy KB. Formulation, in-vitro and in-vivo pharmacokinetic evaluation of simvastatin nanostructured lipid carrier loaded transdermal drug delivery system. Future Journal of Pharmaceutical Sciences. 2019;5(1):1-14. doi: 10.1186/s43094-019-0008-7.14.

Chauhan MK, Sharma PK. Optimization and characterization of rivastigmine nano lipid carrier loaded transdermal patches for the treatment of dementia. Chemistry and Physics of Lipids. 2019;224:104794. doi: https://doi.org/10.1016/j.chemphyslip.2019.104794.

Mendes IT, Ruela ALM, Carvalho FC, Freitas JTJ, Bonfilio R, Pereira GR. Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil. Colloids and Surfaces B: Biointerfaces. 2019;177:274-81. doi: https://doi.org/10.1016/j.colsurfb.2019.02.007.

Gu Y, Tang X, Yang M, Yang D, Liu J. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis. International Journal of Pharmaceutics. 2019;554:235-44. doi: https://doi.org/10.1016/j.ijpharm.2018.11.024.

Raval S, Jani P, Patil P, Thakkar P, Sawant K. Enhancement of bioavailability through transdermal drug delivery of paliperidone palmitate-loaded nanostructured lipid carriers. Therapeutic Delivery. 2021;12(8):583-96. https://doi.org/10.4155/tde-2021-0036

Moura RBP, Andrade LM, Alonso L, Alonso A, Marreto RN, Taveira SF. Combination of lipid nanoparticles and iontophoresis for enhanced lopinavir skin permeation: Impact of electric current on lipid dynamics. European Journal of Pharmaceutical Sciences. 2022;168:106048. doi: https://doi.org/10.1016/j.ejps.2021.106048.

Nnamani PO, Ugwu AA, Nnadi OH, Kenechukwu FC, Ofokansi KC, Attama AA, et al. Formulation and evaluation of transdermal nanogel for delivery of artemether. Drug Delivery and Translational Research. 2021;11(4):1655-74. doi: 10.1007/s13346-021-00951-4.

Jiang T, Ma S, Shen Y, Li Y, Pan R, Xing H. Topical anesthetic and pain relief using penetration enhancer and transcriptional transactivator peptide multi-decorated nanostructured lipid carriers. Drug Delivery. 2021;28(1):478-86. doi: 10.1080/10717544.2021.1889717.

Singh M, Deependra S, Sahu K, Pradhan M, Madhulika, Yadav K, .A method of preparation of Triamcinolone Acetonide encapsulated nanostructured lipid carriers for psoriasis treatment. AU 2021106678 A4.2021.

FOX C, khandhar A, Hoeven N, Erasmus J, Lin S. Nanostructured lipid carriers and stable emulsions and uses thereof. US patent US 2022/0054416 A1.2022.

Chitkara D, Pukale S, Singh A, Mittal A, Sharma S. A lipid-polymer hybrid nanoparticle. US 2021/0369631 A1. 2021.

Domenico F, Jonathan C, Leana R. Nanostructured lipid carrier delivery system, composition, and methods. WO 2021/168573 A1.2021.

Published

14-04-2022

How to Cite

HASSAN, D. H., SHOHDY, J. N., EL-NABARAWI, M., EL-SETOUHY, D. A., & ABDELLATIF, M. M. (2022). NANOSTRUCTURED LIPID CARRIERS FOR TRANSDERMAL DRUG DELIVERY. International Journal of Applied Pharmaceutics, 14(4). https://doi.org/10.22159/ijap.2022v14i4.44564

Issue

Section

Review Article(s)

Most read articles by the same author(s)